$CACI

Cantor Fitzgerald reiterates Overweight on CACI stock at $785 target

Cantor Fitzgerald reiterated an Overweight rating on CACI International (NYSE:CACI) with a $785 price target. The stock trades at $623.38, 9% below its 52-week high. CACI reported 11% revenue growth over the last year, with a $13.78B market cap. Analysts highlight steady profit growth, acquisitions, and strategic focus on high-value tech. Multiple firms raised price targets, citing stable funding and organic growth.

Original reporting
Published Oct 22, 2026, 1:02 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 1:15 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$CACI
Bullish
medium confidence
Mentioned
$CACI
Relevance
4/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$CACIBullishLow
01

Why it matters

Analyst consensus upgrades reinforce a bullish outlook but add little new information.

02

Market read

Provides a brief reaffirmation of bullish analyst sentiment for CACI; limited trading impact.

03

What to watch

Potential macro‑risk from defense spending cuts or geopolitical shifts not addressed in the analyst notes.

Relevance 4/10Novelty 2/10Timing: today

Background

The article aggregates recent analyst upgrades and price targets for CACI International, a defense contractor.

Company-level read

Ticker impact

$CACIBullishMedium confidence
Context

Cantor Fitzgerald reiterated an Overweight rating on CACI with a $785 price target, echoing other analysts' upgrades.

Expected impact

likely modest upward pressure as investors digest the higher target.

Evidence & confidence

Multiple analysts raised targets, but the news is not new; it restates existing sentiment.

Market effects

defense and intelligence sector may see slight positive bias from analyst coverage.

U.S. defense stocks could benefit modestly.

limited to investors tracking CACI and related defense contractors.

Counterpoint

The repeated upgrades may already be priced in; the stock could face a pullback if earnings miss expectations.

Key entities

  • CACI International

    U.S. defense and intelligence services provider.

  • Cantor Fitzgerald

    Investment bank reiterating Overweight rating.

Related articles

$CACIHighAI 8/10

CACI International Inc (CACI) (Q1 2027) Earnings Call Highlights: Record

CACI International reported Q1 2027 earnings with 2.1% organic growth, citing supply chain constraints and budget uncertainty. CEO John Mengucci highlighted a clear strategy and disciplined execution. The company expects stronger growth in the second half, supported by funded backlog growth and recent awards. Integration of acquisitions like ARKA is affecting revenue recognition timing. CACI manages 1,900 programs with varying margins and focuses on long-term investments.

$CACIHighAI 8/10

CACI (CACI) Q1 2027 Earnings Call Transcript

CACI reported Q1 2027 revenue growth of 8%, EBITDA margin of 13.3%, and adjusted EPS increase of 12%. The company generated $133M in free cash flow and won $4.8B in awards. CACI raised its full-year guidance, citing strong demand for its technology, particularly in electronic warfare and space domains. The company is investing in manufacturing capacity to meet demand.

$CACIMed

What CACI International (CACI) Said on Its Q1 Earnings Call

CACI International reported Q1 earnings, highlighting new contracts like Apollo and SOFETOPS 2, and demand for electronic warfare and counter-UAS systems. The company expects to complete Space Development Agency Tranche 1 deliveries this year. CACI opened a new manufacturing center and plans to reduce leverage to 3x by March 2027. Management expressed confidence in the outlook despite a sluggish funding environment.

$CACIHighAI 8/10

CACI Q1 FY27 slides: margin expansion drives guidance raise

CACI International reported Q1 FY27 revenue of $2.47B, up 8.2% YoY but below estimates. EBITDA margin expanded to 13.3%, and EPS beat estimates by 17%. The company raised its FY27 guidance, citing strong profitability and margin expansion. Shares rose 3% premarket. According to CACI, the new guidance reflects improved business visibility and strategic investments.

$CACIMedAI 8/10

CACI (NYSE:CACI) misses Q3 CY2026 sales expectations

CACI reported Q3 CY2026 revenue of $2.47B, missing estimates by 1.4% but beating on adjusted EPS ($7.66 vs $6.60). Adjusted EBITDA also exceeded expectations. The company raised full-year revenue and EPS guidance. Operating margin was steady, but free cash flow margin declined. Backlog remained unchanged at $34B.